“…Those studies, and ours, did not test for effects of saturating concentrations of 4AP (e.g., Serôdio et al, 1996 ). Also, we know of no K + channel antagonist that is specific for the Kv4.3 isoform that we focus on below ( Sanguinetti et al, 1997 ; Sergeant et al, 2005 ; Diochot et al, 2009 ; Jeong et al, 2011 , 2012 ; Fischer et al, 2013 ; Maffie et al, 2013 ; Kimm and Bean, 2014 ; see also Grissmer et al, 1994 ; Mlayah-Bellalouna et al, 2014 ; Haddjeri-Hopkins et al, 2021 ) and therefore did not test for effects of antagonists beside 4AP (e.g., heteropodatoxin, flecainide, phrixotoxin, dapoxetine, duloxetine, rosiglitazone, ajmaline, AmmTX3, SNX-482).…”